Patents by Inventor David C. Hopp

David C. Hopp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions containing hypoglycemically active stilbenoids
    Patent number: 6552085
    Abstract: The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as hypoglycemic agents or to lower serum glucose levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypoglycemic agents.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: April 22, 2003
    Assignee: Insmed Incorporated
    Inventors: Wayne D. Inman, David C. Hopp
  • Methods of using compositions containing hypotriglyceridemically active stilbenoids
    Patent number: 6541522
    Abstract: The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as a dietary supplement to mammals suffering from elevated triglyceride levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypotriglyceridemic agents.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: April 1, 2003
    Assignee: Insmed Incorporated
    Inventors: Wayne D. Inman, David C. Hopp
  • Compositions containing hypoglycemically active stillbenoids
    Patent number: 6410596
    Abstract: The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as hypoglycemic agents or to lower serum glucose levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypoglycemic agents.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: June 25, 2002
    Assignee: Insmed Incorporated
    Inventors: David C. Hopp, Wayne D. Inman
  • Compositions containing hypoglycemically active stilbenoids
    Publication number: 20020058701
    Abstract: The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as hypoglycemic agents or to lower serum glucose levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypoglycemic agents.
    Type: Application
    Filed: August 2, 2001
    Publication date: May 16, 2002
    Inventors: Wayne D. Inman, David C. Hopp
  • Compositions containing hypotriglyceridemically active stilbenoids
    Publication number: 20020058708
    Abstract: The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as a dietary supplement to mammals suffering from elevated triglyceride levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypotriglyceridemic agents.
    Type: Application
    Filed: August 2, 2001
    Publication date: May 16, 2002
    Inventors: Wayne D. Inman, David C. Hopp
  • COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS
    Publication number: 20020058707
    Abstract: The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as hypoglycemic agents or to lower serum glucose levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypoglycemic agents.
    Type: Application
    Filed: August 2, 2001
    Publication date: May 16, 2002
    Inventors: David C. Hopp, Wayne D. Inman
  • Compositions containing hypotriglyceridemically active stilbenoids
    Publication number: 20020055541
    Abstract: The use of isolated or purified stilbenoid compounds including longistyline A-2-carboxylic acid as a dietary supplement to mammals suffering from elevated triglyceride levels is described. The invention also relates to the use of such stibenoid compounds in combination with other hypotriglyceridemic agents.
    Type: Application
    Filed: August 2, 2001
    Publication date: May 9, 2002
    Applicant: Shaman Pharmaceuticals, Inc.
    Inventors: Wayne D. Inman, David C. Hopp
  • Bioactive acetogenins
    Patent number: 5955497
    Abstract: Novel acetogenins isolated from Annona squamosa of the family Annonaceae are described. The substantially pure acetogenins of the invention exhibit cytotoxicity to human tumor cell lines as well as selective cytotoxicity for various human tumor cell lines.
    Type: Grant
    Filed: February 24, 1998
    Date of Patent: September 21, 1999
    Assignee: Purdue Research Foundation
    Inventors: Jerry L. McLaughlin, David C. Hopp